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Do We Need Trials To Prove Equivalency/Superiority to
Transesophageal Echocardiography?*Ziyad M. Hijazi, MD, MPH,yz Hussam Suradi, MDySEE PAGE 1036I t may be surprising to realize that the initial workin intracardiac echocardiography (ICE) imagingappeared in the early 1960s, preceding the devel-
opment of interventional catheterization procedures
(1). The increasingly sophisticated catheter-based
structural interventions that have emerged over the
past decade, stimulated the growth of ICE to become
an established imaging modality that holds distinct
advantages for use in practice such as transseptal
access (2), atrial and ventricular septal defects closure
(3), and radiofrequency ablation for cardiac arrhyth-
mias (4). Furthermore, in our center, we use it
exclusively to guide all congenital and structural
interventional procedures. As opposed to transeso-
phageal echocardiogram (TEE), ICE offers compara-
ble, if not superior, imaging without the need for
general anesthesia. The use of ICE also allows the
interventionalist to simultaneously perform the pro-
cedure as well as the imaging part without the need
of additional echocardiographic personnel.
The introduction of percutaneous left atrial
appendage (LAA) closure into clinical practice has
stirred considerable interest to reduce the risk of
thromboembolism in patients with atrial ﬁbrillation,
with several clinical trials demonstrating high proce-
dural success rates and noninferiority to warfarin for
preventing embolic stroke (5). The procedure is fairly
intricate with echocardiographic guidance being
an essential tool at all stages of this procedure.*Editorials published in the JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
From the ySidra Cardiovascular Center of Excellence, Sidra Medical and
Research Center, Doha-Qatar, Qatar; and the zRush Center for Congenital
and Structural Heart Disease, Rush University Medical Center, Chicago,
Illinois. Both authors have reported that they have no relationships
relevant to the contents of this paper to disclose.Pre-procedural echocardiography is required to screen
suitable candidates and to deﬁne LAA morphology
and dimension. Periprocedural echocardiography has
amajor role in guiding and deployment of the device as
well as for screening for complications and assessment
of procedural success. Post-procedural echocardiog-
raphy is important in the surveillance and monitoring
of long-term outcome, including complications. TEE is
widely considered the gold standard tool in visualizing
the LAA and is typically used to guide implantation of
the LAA device. To obviate the need for endotracheal
and esophageal intubation, there has been increased
interest in performing the procedure under ICE guid-
ance only. Over the past decade, there have been
several reports discussing the utilization of ICE in
guiding LAA closure; however, to date, comparative
studies between the 2 imaging modalities in guiding
LAA closure are lacking (6,7).
In this issue of JACC: Cardiovascular Interventions,
Berti et al. (8) contribute signiﬁcantly to the current
experience regarding the utility of periprocedural ICE
as an alternative to TEE in guiding LAA occlusion
procedures. This is the largest reported observational
study from 2 centers addressing the application of
ICE as an imaging modality in guiding LAA deviceclosure. They report the short-term and mid-term re-
sults from 121 patients with mean age of 77 years, who
underwent ICE-guided percutaneous LAA occlusion
using Amplatzer Cardiac Plug I and II devices (St. Jude
Medical, St. Paul, Minnesota). All patients had non-
rheumatic atrial ﬁbrillation with high stroke risk and
absolute contraindication for oral anticoagulation. The
ICE catheter was positioned either in the right atrium
or coronary sinus. From those positions, the LAA
dimension was deﬁned and followed by implantation
of the appropriate device size. The LAA dimension
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1046obtained by ICE correlated well with those obtained
by angiography and, to a lesser degree, with pre-
procedural TEE. In the majority of cases, the initial
device size selected based on ICE measurements was
implanted successfully. Excellent technical (96.7%)
and procedural outcomes (93.4%) were achieved with
4 patients having major adverse events. These data
support the pre-existing literature reporting the
feasibility of ICE imaging in guiding LAAdevice closure
as an acceptable alternative to TEE (9). However, what
conclusions can be drawn regarding the broad appli-
cability using ICE to assist in such interventions?
Although we do believe that ICE imaging is able to
perform the intraprocedural tasks typically provided
by TEE, nevertheless, as the investigators highlight in
their discussion, there are several deﬁciencies in the
study that may limit its broad applicability. Because
accurate echocardiographic measurement of the LAA
anatomy is critically important for successful device
closure, using ICE instead of TEE to routinely guide
LAA device implantation would only be clinically
practical if ICE imaging were able to produce high-
quality images consistently. Although we recognize
that there is no generally accepted standard protocol
for LAA imaging with ICE, it is self-evident that com-
plete imaging of this complex 3-dimensional structure
requires multiple 2-dimensional planes at a minimum
to properly deﬁne its dimensions. In this study, LAA
imaging was obtained by positioning the ICE catheter
either in the right atrium or coronary sinus; however,
the investigators offer no consistent methodology
(views) by which the imaging was performed or
description of the quality of the images acquired. In
our experience, right atrial views are rarely sufﬁcient
to visualize the complex anatomy of the LAA, partly
due to the variable interatrial septum orientation and
distance from the LAA to the ICE position in the right
atrium (the LAA lies in the echo far ﬁeld, which often
requires lowering the frequency to increase the imag-
ing ﬁeld depth, resulting in signiﬁcantly compromised
far-ﬁeld tissue resolution). This imaging limitation can
be easily overcome by placing the ICE catheter in the
left pulmonary artery, in closer proximity to the LAA.
Similarly, positioning the catheter in the left pulmo-
nary artery offers superior image quality of the LAA
and ease of probe manipulation as opposed to that in
the coronary sinus (10). Certainly, there is a signiﬁcant
learning curve in order to gain proﬁciency innavigating the ICE catheter within the heart and to
obtain pristine images. Although not explicitly stated
in the study methodology, it is assumed that all of the
operators in the study were highly skilled in ICE
imaging. Another unavoidable criticism is that,
the investigators report a high level of agreement
regarding device size selection based on ICE and pre-
procedural TEE imaging. However, the validity of
such a conclusion is compromised as the operators
were not blinded to the 2 imaging modalities. More-
over, we agree with the investigators that it may be
inappropriate to generalize the results of the study to
all ICE systems, because a wide variety of ICE systems
is commercially available with variable transducer
functionality. Finally, patients left with relevant
residual peridevice leakages experience no real beneﬁt
from the procedure and have to stay on anti-
coagulation therapy. The investigators outline in their
discussion the importance of residual peridevice leak;
however, they do not comment on either the echo-
cardiographic or angiographic assessment of device
sealing of the LAA, which is an important variable of
the success of the procedure.
The investigators should be praised for their excel-
lent technical and procedural outcomes with results
very comparable to those reported with TEE-guided
implantation (11). Although imaging with ICE is inva-
sive and may increase costs, it offers less procedural
discomfort for the patient and potentially reduces the
procedural time. It also eliminates the need for an
anesthesiologist and echocardiographic personnel,
enhancing in turn the cost-effectiveness of using this
imaging tool. Although it can be concluded from this
study that the use of periprocedural ICE is feasible and
safe in guiding LAAdevice closure, this study, likemost
observational studies, serves as an initial step toward a
pivotal trial that will compare the 2 imaging modalities
in relation to LAA device closure. Perhaps future en-
deavors should be directed toward eliminating the
need for pre-procedural TEE such that all the tasks
required for LAA device closure can be achieved solely
by ICE imaging thereby minimizing the excessive cost
and risk associated with duplicative TEE studies.
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